- Home
- ALDX vs GCO Comparison
ALDX vs GCO Comparison
Compare ALDX & GCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- GCO
- Stock Information
- Founded
- ALDX 2004
- GCO 1924
- Country
- ALDX United States
- GCO United States
- Employees
- ALDX N/A
- GCO N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- GCO Clothing/Shoe/Accessory Stores
- Sector
- ALDX Health Care
- GCO Consumer Discretionary
- Exchange
- ALDX Nasdaq
- GCO Nasdaq
- Market Cap
- ALDX 296.0M
- GCO 321.1M
- IPO Year
- ALDX 2014
- GCO N/A
- Fundamental
- Price
- ALDX $4.72
- GCO $31.23
- Analyst Decision
- ALDX Strong Buy
- GCO Buy
- Analyst Count
- ALDX 2
- GCO 3
- Target Price
- ALDX $9.50
- GCO $32.67
- AVG Volume (30 Days)
- ALDX 625.1K
- GCO 84.4K
- Earning Date
- ALDX 11-05-2025
- GCO 12-05-2025
- Dividend Yield
- ALDX N/A
- GCO N/A
- EPS Growth
- ALDX N/A
- GCO N/A
- EPS
- ALDX N/A
- GCO N/A
- Revenue
- ALDX N/A
- GCO $2,362,215,000.00
- Revenue This Year
- ALDX N/A
- GCO $4.60
- Revenue Next Year
- ALDX $63.48
- GCO $2.14
- P/E Ratio
- ALDX N/A
- GCO N/A
- Revenue Growth
- ALDX N/A
- GCO 2.66
- 52 Week Low
- ALDX $1.14
- GCO $16.19
- 52 Week High
- ALDX $7.20
- GCO $44.80
- Technical
- Relative Strength Index (RSI)
- ALDX 34.90
- GCO 56.92
- Support Level
- ALDX $4.85
- GCO $27.85
- Resistance Level
- ALDX $5.27
- GCO $31.27
- Average True Range (ATR)
- ALDX 0.27
- GCO 1.16
- MACD
- ALDX -0.05
- GCO 0.19
- Stochastic Oscillator
- ALDX 14.15
- GCO 75.97
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About GCO Genesco Inc.
Genesco Inc. sells footwear, headwear, sports apparel, and accessories through four main segments. The Journeys Group generates the highest revenue, encompassing the Journeys, Journeys Kidz, and Little Burgundy brands, along with e-commerce and catalog sales. The Schuh Group targets teenagers and young adults aged 16 to 24, focusing on casual and athletic footwear. The Johnston & Murphy Group operates retail shops and factory stores across the United States. Finally, the Genesco Brands Group designs and sources licensed footwear for brands like Levi's, Dockers, and G.H. Bass.